Drawbridge Health’s NanoDrop gains FDA clearance for at-home blood sampling
- Drawbridge Health, a pioneering healthcare technology company, announced an innovative achievement today as its advanced at-home blood sampling device, NanoDrop Lancet, received United States Food and Drug Administration (FDA) 510(k) clearance for over-the-counter (OTC) use. This marks a significant milestone in the healthcare industry, as NanoDrop...
More Articles
How to Effectively Integrate AI into Clinical Trials
Since its inception, artificial intelligence (AI) has continually disrupted practices across all industries. As more and more healthcare researchers and clinicians adopt AI, experts have noted the impact of AI on clinical research and...Revolutionizing Clinical Trial Data Tracking, Analysis with Technology
In the realm of healthcare technology, one of the most critical and revolutionary aspects is the process of tracking and analyzing clinical trial data. Clinical trials are the backbone of medical advancements, paving the way for...Expanding Product Portfolios Through Technology Integration
The biotechnology and pharmaceutical industries have long been at the forefront of technological innovation, leveraging cutting-edge advancements to improve healthcare outcomes and enhance product portfolios. In an era where...FDA Publishes Draft Guidance for Decentralized Clinical Trials
Yesterday, the FDA published a copy of its draft guidance for decentralized clinical trials, adding to previously issued guidelines. Clinical trial participants may be able to bring trials to their...How to Integrate Remote Patient Monitoring Across Cancer Care Settings
In recent years, remote patient monitoring tools have gained traction as they have been introduced and integrated into patient care. The uptick in the use of remote patient monitoring tools and platforms was driven, in part, by travel...How Can Remote Patient Monitoring Improve OUD Care?
Opioid use disorder (OUD) has become a very prevalent substance abuse issue. According to the CDC, approximately 75% of overdoses in 2022 involved an opioid in the United States. The pharmaceutical industry has contributed significantly to...Sponsored by Glooko
How Digital Companions, Therapeutics Are Changing Healthcare
Thanks to the 2020 COVID-19 pandemic, the medical industry has been hurled into a digital healthcare environment to support and provide care to patients while social distancing, leading to improved...Digital Health Tools Are Perceived as an Advantage to 93% of Physicians
Between 2016 and 2022, the AMA surveyed approximately 1,300 providers in the United States for AMA Digital Health Research. This data collected information on motivations and requirements for digital...Sponsored by Glooko
Democratizing Access to Clinical Trials through Remote Patient Monitoring
Digital monitoring techniques quickly embraced during the COVID-19 pandemic are changing the relationship between clinical trials and patients, paving the way to increased enrollment, greater patient...Revolutions in Neuroscience: Deep Brain Stimulation
Deep brain stimulation (DBS) — a neurosurgical approach for treatment-resistant neurological disorders — has become a revolutionary addition to the field of neuroscience and a beneficial tool for neurologists, neurosurgeons,...Sponsored by Emids
